J066--NEW – Roche Benchmark Ultra Services
Veterans Affairs · 257-NETWORK CONTRACT OFFICE 17 (36C257)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25726Q0808 in this department, oldest first.
- Jul 30, 2026Special NoticeOpen
- Aug 24, 2026Award NoticeROCHE DIAGNOSTICS CORPORATION · $218KOpen
- Aug 24, 2026 · this noticeJustification (Sole Source)ROCHE DIAGNOSTICS CORPORATION · $218K
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- The agency intends to buy without full competition. Read the justification for the reason and the named source.
What the notice says
DEPARTMENT OF VETERANS AFFAIRS NETWORK CONTRACTING OFFICE 17 (NCO 17) South Texas Veterans Health Care System (STVHCS) JUSTIFICATION FOR OTHER THAN FULL AND OPEN COMPETITION (Sole Source) Prepared in Accordance with RFO FAR 6.103-1(b) and the Revolutionary FAR Overhaul (RFO) to the FAR Contracting Activity: Department of Veterans Affairs, Network Contracting Office 17 (NCO 17), South Texas Veterans Health Care System (STVHCS) Acquisition Plan Action ID: 36C257-26-AP-4408 Requisition Number: 671-26-4-121-2325 JOFOC Log Number: FY26 - NCO 17 - 2033 Requirement Title: Roche Benchmark Ultra Servic… (show all)
es Contract Type: Firm-Fixed-Price (FFP), Commercial Service, processed in accordance with FAR Part 12 Estimated Total Value (Base + Options): $249,252.94 IDENTIFICATION OF AGENCY AND CONTRACTING ACTIVITY This is a Justification for Other Than Full and Open Competition prepared by the Department of Veterans Affairs, Network Contracting Office 17 (NCO 17), in support of a requirement of the South Texas Veterans Health Care System (STVHCS), Pathology & Laboratory Medicine Service. NATURE AND DESCRIPTION OF THE ACTION BEING APPROVED The Department of Veterans Affairs (VA), Network Contracting Office 17 (NCO 17), proposes to award a new firm-fixed-price commercial services contract, using the procedures of FAR Part 12 as implemented by the Revolutionary FAR Overhaul (RFO), to Roche Diagnostics Corporation for service and maintenance support of three (3) Roche BenchMark Ultra automated Immunohistochemistry (IHC)/In Situ Hybridization (ISH) staining instruments located at the South Texas Veterans Health Care System (STVHCS), Pathology and Laboratory Medicine Service, Specialty Laboratory in San Antonio, Texas. The proposed action is a follow-on to incumbent sole source contract 36C25721P1359 and will be awarded as a new stand-alone contract. DESCRIPTION OF SUPPLIES/SERVICES AND ESTIMATED VALUE The STVHCS has a continued need for comprehensive, OEM-authorized service and maintenance support for three Roche BenchMark Ultra instruments (Serial Numbers 311977, 311975, and 316490) that perform critical IHC/ISH diagnostic testing for Veteran patients. Under the contemplated contract, the contractor shall provide: unlimited on-site service support by a Certified Roche Field Service Engineer (FSE) Monday through Friday, 8:00 a.m. to 5:00 p.m. local time (excluding Federal holidays); a 24/7 customer support line to report service issues; repair service dispatch within 48 hours of call receipt (same-day dispatch when two or more instruments are down); all repair and annual preventative maintenance (PM) parts and associated shipping costs; one annual PM service per instrument; on-site applications troubleshooting and up to five (5) days of applications support annually by a Certified Roche Field Applications Specialist (FAS); and installation of all manufacturer operational modifications by an FSE. The estimated total value of this acquisition, including a one-year base period and four (4) one-year option periods, is $249,252.94. Product Service Code (PSC): J065 -- Maintain, Repair, Rebuild of Equipment: Medical, Dental, and Veterinary Equipment and Supplies. NAICS Code: 811210 -- Electronic and Precision Equipment Repair and Maintenance (Size Standard $34M). This acquisition is being processed as a commercial service under FAR Part 12, as revised under the Revolutionary FAR Overhaul (RFO). IDENTIFICATION OF THE STATUTORY AUTHORITY The statutory authority permitting other than full and open competition is 41 U.S.C. § 3304(a)(1), as implemented by RFO FAR 6.103-1(b), "One Responsible Source" (formerly FAR 6.302-1, "Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements"). Under the Revolutionary FAR Overhaul (RFO) restructuring of FAR Part 6, the seven exceptions to full and open competition previously codified at FAR 6.302-1 through 6.302-7 have been renumbered and streamlined as RFO FAR 6.103-1 through 6.103-7, with the only-one-responsible-source authority now specifically located at RFO FAR 6.103-1(b). This action is justified under RFO FAR 6.103-1(b) because the supplies and services required are available from only one responsible source and no other supplies or services will satisfy the agency's requirements. DEMONSTRATION OF CONTRACTOR'S UNIQUE QUALIFICATIONS Roche Diagnostics Corporation is the sole manufacturer and distributor of the BenchMark Ultra automated workflow series and associated reagents, consumables, diagnostic software, and hardware, as documented in its sole-source letter. Roche has certified that it is the only manufacturer and distributor of the BenchMark Ultra platform and that service and maintenance of the instrument family must be performed exclusively by Roche Diagnostics-trained Field Service Engineers (FSEs), or the manufacturer warranty is rendered null and void. The proprietary nature of the technology contained within the instruments including closed-architecture diagnostic software, proprietary calibration procedures, and restricted access to OEM parts, firmware, and technical documentation requires that only Roche Diagnostics perform certain maintenance and service procedures. The operator's manual specifies that routine maintenance activities performed by end users are limited; all other maintenance and repair activities must be performed by Roche FSEs. No third-party service provider has access to the OEM-authorized parts, diagnostic tools, firmware updates, or manufacturer training necessary to safely and effectively service these instruments without compromising patient safety, College of American Pathologists (CAP) accreditation, or VHA Directive 1106 compliance. Each of the three BenchMark Ultra instruments at STVHCS performs a unique set of IHC/ISH assays that the other instruments cannot perform. Any prolonged downtime of one or more instruments would result in significant delay or inability to perform essential diagnostic testing, adversely affecting Veteran patient care. Only Roche Diagnostics can provide OEM-authorized service that maintains instrument performance within manufacturer specifications and preserves warranty and regulatory compliance. Accordingly, Roche Diagnostics Corporation is the only responsible source capable of satisfying the agency's requirements under RFO FAR 6.103-1(b). EFFORTS MADE TO ENSURE OFFERS ARE SOLICITED FROM AS MANY POTENTIAL SOURCES AS PRACTICABLE In accordance with RFO FAR Part 10 and VAAR 810, the Contracting Officer conducted extensive market research, as documented in Market Research Report MRR-36C257-26-AP-4408. Research included: Searching the SBA VetCert database using the keywords "BenchMark Ultra" and NAICS 811210 to identify certified capable SDVOSBs and VOSBs (no results). Reviewing prior market research and acquisition history for similar requirements, including sole source contract 36C25726P0473 for a BenchMark Ultra Plus instrument and incumbent service contract 36C25721P1359. Searching SAM.gov, SBA small business databases, Federal Prison Industries (UNICOR), AbilityOne, and GSA eLibrary (including Roche's GSA contract V797P-7347A, which covers cost-per-test arrangements rather than dedicated service contracts). Additionally, pursuant to RFO FAR 5.201 and 5.207, the Government posted a Notice of Intent (NOI) 36C25726Q0808 to SAM.gov on July 30, 2026, for ten (10) calendar days, inviting responses from any responsible sources capable of meeting the requirement. No responses or capability statements were received during the posting period. All market research efforts consistently support the conclusion that no other source, small business or otherwise, is capable of providing OEM-authorized BenchMark Ultra service and maintenance. Determination Regarding the VA Rule of Two and Use of Set-Asides. The VA Rule of Two requires that before using a non-competitive procedure, the Contracting Officer determine whether two or more VetCert-listed SDVOSBs
Who won similar work
12 award notices on SAM.gov in the last 24 months. Matched by: Same office (257-NETWORK CONTRACT OFFICE 17 (36C257)), same product/service code (PSC) J066 and NAICS 811210.
Single-winner award sizes (12): middle half $68K to $452K, median $125K; range $16K to $1.8M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| RICHARD-ALLAN SCIENTIFIC LLC | 2 | $109K | Jul 24, 2026 |
| CEPHEID SUNNYVALE 94089 | 1 | $1.8M | Mar 12, 2026 |
| XENEX DISINFECTION SERVICES INC. | 1 | $871K | Jan 15, 2025 |
| ILLUMINA, INC. · $ILMN · $4.5B | 1 | $497K | Jun 12, 2025 |
| FULL SPECTRUM GROUP, LLC | 1 | $438K | Apr 1, 2025 |
| LEICA MICROSYSTEMS INC. | 1 | $183K | Jun 12, 2026 |
| NEXUS GROUP, LLC | 1 | $144K | Mar 24, 2026 |
| BIOMERIEUX INC | 1 | $105K | Aug 12, 2026 |
| RADIOMETER AMERICA, INC. | 1 | $72K | Jul 14, 2026 |
| BECKMAN COULTER, INC | 1 | $56K | Nov 18, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $ILMN reported $4.5B revenue (12 months to Jun 28, 2026). The median single-winner award in these 12 past awards, $125K, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Aug 12, 2026BIOMERIEUX INC$105KJ066--NEW - BioMerieux Biofire TORCH ServicesNo listed company matched (Materiality N/A)
- Jul 24, 2026RICHARD-ALLAN SCIENTIFIC LLC$93KJ066-- STX Richard-Allan Epredia SVCNo listed company matched (Materiality N/A)
- Jul 14, 2026RADIOMETER AMERICA, INC.$72KJ066--NEW | CTX ABL ServiceNo listed company matched (Materiality N/A)
- Jun 12, 2026LEICA MICROSYSTEMS INC.$183KJ066-- Leica Cerebro ServicesNo listed company matched (Materiality N/A)
- Apr 22, 2026RICHARD-ALLAN SCIENTIFIC LLC$16KJ066--Lab Histology Equipment SMANo listed company matched (Materiality N/A)
- Mar 24, 2026NEXUS GROUP, LLC$144KJ066--NEW - CTX Peloris IIINo listed company matched (Materiality N/A)
- Mar 12, 2026CEPHEID SUNNYVALE 94089$1.8MJ066--VISN 17 GeneXpert Analyzer M&R Consolidated IDIQNo listed company matched (Materiality N/A)
- Nov 18, 2025BECKMAN COULTER, INC$56KJ066--DxM 1040 MicroScan WalkAway PMNo listed company matched (Materiality N/A)
- Aug 6, 2025BECTON, DICKINSON AND COMPANY$30KJ066--NEW - BD FX ServiceMateriality: <0.01% of $BDX revenue (Low) SEC
- Jun 12, 2025ILLUMINA, INC.$497KNEW CTX Illumina NextSeq Service ContractMateriality: 0.01% of $ILMN revenue (Low) SEC
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (6 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 4 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.